EXACT Sciences Corp (NASDAQ:EXAS)

CAPS Rating: 2 out of 5

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

Recs

0
Player Avatar foolfully (61.01) Submitted: 11/21/2012 4:20:06 PM : Outperform Start Price: $9.28 EXAS Score: +69.35

100

Featured Broker Partners


Advertisement